{"text": "Supplementary Material\n\nSupplementary Table 1. HLA-A variants in patients carrying rs1061235T but not HLA-A*31:01. rs1061235T without A*31:01 HLA-A*33:01 HLA-A*33:03 Total N N positive OR (95% CI) P-valuea N positive OR (95% CI) P-valuea N positive OR (95% CI) P-valuea CBZ-HSS 3 1 1 CBZ-MPE 20 3 1 2 CBZ-SJS/TEN 9 - - - CBZ-AGEP 1 1 1 - All CBZ cases 33 5 4.98 (0.90-34.08) 0.034 2 4.39 (0.22-264.95) 0.238 3 3.35 (0.37-41.55) 0.326 HSS/MPE 23 4 5.83 (0.91-43.18) 0.033 1 2.84 (0.35-227.41) 0.457 3 4.48 (0.49-56.09) 0.112 CBZ-tolerant 88 3 1 2 AGEP, Acute Generalized Exanthematous Pustulosis; CBZ, carbamazepine; CI, confidence interval; HSS, drug-induced hypersensitivity syndrome; MPE, maculopapular exanthem; SJS/TEN, Stevens-Johnson syndrome/toxic epidermal necrolysis; OR, odds ratio aCalculated using Fisher s exact test Significant P-values are indicated in bold. "}